TWO SIGMA INVESTMENTS, LP - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$341,376
-98.3%
25,400
-97.9%
0.00%
-98.2%
Q1 2023$19,637,767
-45.2%
1,184,425
-38.5%
0.06%
-50.0%
Q4 2022$35,806,674
+60.9%
1,925,090
+11.0%
0.11%
+47.4%
Q3 2022$22,256,000
+585.2%
1,734,723
+274.4%
0.08%
+590.9%
Q2 2022$3,248,000
-63.6%
463,325
-56.9%
0.01%
-57.7%
Q1 2022$8,914,000
+73.0%
1,075,282
+41.3%
0.03%
+136.4%
Q4 2021$5,153,000
+748.9%
761,079
+564.3%
0.01%
+1000.0%
Q3 2021$607,000
-69.5%
114,571
-66.9%
0.00%
-80.0%
Q2 2021$1,990,000
-25.7%
346,065
-40.5%
0.01%
-28.6%
Q1 2021$2,680,000
+117.4%
581,253
+57.5%
0.01%
+75.0%
Q4 2020$1,233,000
-37.4%
369,071
-13.4%
0.00%
-60.0%
Q2 2020$1,969,000
+3838.0%
426,197
+3160.6%
0.01%
Q1 2020$50,000
-98.1%
13,071
-98.2%
0.00%
-100.0%
Q4 2019$2,673,000
+886.3%
712,757
+405.5%
0.01%
+700.0%
Q4 2018$271,000
+298.5%
141,004
+550.6%
0.00%
Q2 2018$68,000
+51.1%
21,673
+15.9%
0.00%
Q1 2018$45,000
-97.2%
18,703
-95.4%
0.00%
-100.0%
Q4 2017$1,592,000
+2111.1%
407,175
+562.8%
0.01%
Q1 2016$72,00061,4340.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders